Dana Farber Cancer Center Institute — Boston, Massachusetts

Dana Farber Cancer Center Institute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Center Institute has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer.

Sponsors: University of Alabama at Birmingham.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Center Institute?

Dana Farber Cancer Center Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Center Institute conducted?

Dana Farber Cancer Center Institute has 1 clinical trials on record. Their work covers Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer.

Is Dana Farber Cancer Center Institute accredited by Crixeo Health?

Dana Farber Cancer Center Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Center Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.